Intracellular Alpha-Synuclein and Immune Cell Function

Intracellular alpha-synuclein has numerous effects on different functions of the cell. Although it is expressed in a wide spectrum of cell types from different lineages, most of our knowledge about it was generated by studying neuronal or glial cells. However, the role of immune cells in Parkinson’s...

Full description

Bibliographic Details
Main Authors: Veselin Grozdanov, Karin M. Danzer
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-10-01
Series:Frontiers in Cell and Developmental Biology
Subjects:
Online Access:https://www.frontiersin.org/article/10.3389/fcell.2020.562692/full
id doaj-237745dd08e54f5b8ff6de2e4c502fab
record_format Article
spelling doaj-237745dd08e54f5b8ff6de2e4c502fab2020-11-25T01:53:22ZengFrontiers Media S.A.Frontiers in Cell and Developmental Biology2296-634X2020-10-01810.3389/fcell.2020.562692562692Intracellular Alpha-Synuclein and Immune Cell FunctionVeselin GrozdanovKarin M. DanzerIntracellular alpha-synuclein has numerous effects on different functions of the cell. Although it is expressed in a wide spectrum of cell types from different lineages, most of our knowledge about it was generated by studying neuronal or glial cells. However, the role of immune cells in Parkinson’s disease and related synucleinopathies has recently emerged. Altered immune cell phenotypes and functions have been reported not only in animal models, but also in human disease. While the response of immune cells to extracellular alpha-synuclein has been thoroughly studied, insights into the effects of endogenously expressed or taken-up alpha-synuclein on the function of immune cells remain scarce. Such insights may prove to be important for understanding the complex cellular and molecular events resulting in neurodegeneration and aid the development of novel therapies. We review the current state of knowledge about how alpha-synuclein and its pathologic manifestations affect the phenotype and function of peripheral and central nervous system (CNS) immune cells, and discuss the potential of this topic for advancing our understanding of synucleinopathies.https://www.frontiersin.org/article/10.3389/fcell.2020.562692/fullalpha-synucleinParkinson’s diseaseimmune cell functionmicrogliamonocytes
collection DOAJ
language English
format Article
sources DOAJ
author Veselin Grozdanov
Karin M. Danzer
spellingShingle Veselin Grozdanov
Karin M. Danzer
Intracellular Alpha-Synuclein and Immune Cell Function
Frontiers in Cell and Developmental Biology
alpha-synuclein
Parkinson’s disease
immune cell function
microglia
monocytes
author_facet Veselin Grozdanov
Karin M. Danzer
author_sort Veselin Grozdanov
title Intracellular Alpha-Synuclein and Immune Cell Function
title_short Intracellular Alpha-Synuclein and Immune Cell Function
title_full Intracellular Alpha-Synuclein and Immune Cell Function
title_fullStr Intracellular Alpha-Synuclein and Immune Cell Function
title_full_unstemmed Intracellular Alpha-Synuclein and Immune Cell Function
title_sort intracellular alpha-synuclein and immune cell function
publisher Frontiers Media S.A.
series Frontiers in Cell and Developmental Biology
issn 2296-634X
publishDate 2020-10-01
description Intracellular alpha-synuclein has numerous effects on different functions of the cell. Although it is expressed in a wide spectrum of cell types from different lineages, most of our knowledge about it was generated by studying neuronal or glial cells. However, the role of immune cells in Parkinson’s disease and related synucleinopathies has recently emerged. Altered immune cell phenotypes and functions have been reported not only in animal models, but also in human disease. While the response of immune cells to extracellular alpha-synuclein has been thoroughly studied, insights into the effects of endogenously expressed or taken-up alpha-synuclein on the function of immune cells remain scarce. Such insights may prove to be important for understanding the complex cellular and molecular events resulting in neurodegeneration and aid the development of novel therapies. We review the current state of knowledge about how alpha-synuclein and its pathologic manifestations affect the phenotype and function of peripheral and central nervous system (CNS) immune cells, and discuss the potential of this topic for advancing our understanding of synucleinopathies.
topic alpha-synuclein
Parkinson’s disease
immune cell function
microglia
monocytes
url https://www.frontiersin.org/article/10.3389/fcell.2020.562692/full
work_keys_str_mv AT veselingrozdanov intracellularalphasynucleinandimmunecellfunction
AT karinmdanzer intracellularalphasynucleinandimmunecellfunction
_version_ 1724991370073997312